HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue120,77477,407104,521108,664
Cost of Revenue53,79338,23756,10659,941
Gross Profit66,98139,17048,41548,723
Operating Expenses
Research Development10,9885,6455,3926,420
Selling General and Administrative45,82532,60741,43640,409
Non Recurring----
Others----
Total Operating Expenses115,99078,042105,656109,589
Operating Income or Loss4,784-635-1,135-925
Income from Continuing Operations
Total Other Income/Expenses Net-12,759-1,986-1,943-2,683
Earnings Before Interest and Taxes4,784-635-1,135-925
Interest Expense-5,367-713-639-846
Income Before Tax-7,975-2,621-3,078-3,608
Income Tax Expense-3,676-6051,22915,431
Minority Interest----
Net Income From Continuing Ops-4,299-2,016-4,307-19,039
Non-recurring Events
Discontinued Operations1,3771,1511,1511,151
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,922-865-4,307-19,039
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,922-865-4,307-19,039